Bristol-Meyers Squibb Co. Stock Drops After Investigation Announcement
NEW YORK-Federal investigators are looking at pharmaceutical giant Bristol-Meyers Squibb Co. after reports that the company gave free drugs and devices to doctors in exchange for purchase of other Bristol drugs.
Bristol stock fell 3% Tuesday after the announcement. A company spokesperson said it was cooperating with the federal investigation and felt its pricing practices complied with the law.
Investigators are also looking at whether the company encouraged doctors to bill Medicare and Medicaid improperly.
Information from www.usatoday.com
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
